2011年8月3日美国食品药品管理局(FDA)批准首个用于刺尾蝎属蝎螫伤的特效治疗药物Anascorp。重度毒蝎螫伤常见于婴幼儿,通常会引起呼吸短促、肺内积液、呼吸困难、多涎、视力模糊、言语不清、吞咽困难、异常眼运动、肌肉抽搐、行走 August 3, 2011 The Food and Drug Administration (FDA) approved the first Anascorp drug for the treatment of Scorpion’s scabies. Severe poison scorpion 螫 injury common in infants and young children, usually cause shortness of breath, fluid in the lungs, difficulty breathing, salivation, blurred vision, speechless, swallowing difficulties, abnormal eye movements, muscle twitching, walking